Efforts to associate biochemical NP-C phenotypes with clinical severity have shown that patients with severe neurological forms of NP-C show a “classic” biochemical phenotype by the filipin and/or cholesteryl esterification tests [24–27] and tend to have low or undetectable levels of immunoreactive NPC1 [27–29]. Here, NPC1 is linked to nasopharyngeal carcinoma.